Join Now

Yearly Archives: 2022

Renalytix to Appoint Timothy Scannell to Board of Directors

By Natalie Themm | Published February 23, 2022

Renalytix announced its intention to appoint Timothy Scannell to its board of directors as an independent non-executive director.

Posted in BioUtah News | Tagged | Leave a comment

SkinTE® Met Primary and Secondary Endpoints in Multicenter, Randomized Controlled Trial in Venous Leg Ulcers

By Natalie Themm | Published February 23, 2022

PolarityTE announced results from a multi-center randomized controlled trial evaluating treatment of Venous Leg Ulcers (VLU) with its investigational product SkinTE® plus standard of care (SOC) vs SOC alone (NCT03881267).

Posted in BioUtah News | Tagged | Leave a comment

LEGISLATIVE ALERT: HB60 and HB63 Could Pose Problems for Life Sciences Companies in Utah

By admin | Published February 17, 2022

In this year’s legislative session, two bills could be problematic for life sciences companies in Utah. HB60 prohibits employers from requiring proof of vaccination from employees or patrons. While it provides an exemption for federally regulated entities like hospitals, it does not provide an exemption for life sciences employees who interact with those institutions who […]

Posted in BioUtah News | Leave a comment

The BioHive Descends on Capitol Hill

By admin | Published February 17, 2022

Life Sciences Day on Capitol Hill was held on February 16 filling the Capitol rotunda with 24 companies showcasing their innovations to lawmakers and collectively, reflecting the strength of Utah’s BioHive. Lt. Governor Deidre Henderson was on hand to personally visit with company representatives and learn about the important work they’re doing to advance healthcare. […]

Posted in BioUtah News | Leave a comment

Transit Scientific’s New Scoring Sheath Delivers Low Pressure Angioplasty Treatment in Calcified Arteries

By Natalie Themm | Published February 17, 2022

First-of-its kind metal-alloy angioplasty scoring sheath effective in treatment of critical arterial stenosis

Posted in BioUtah News | Tagged | Leave a comment

ARUP Researchers’ Prolific Publications, Presentations Helped Advance Lab Medicine in 2021

By Natalie Themm | Published February 17, 2022

Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles in academic journals, medical guideline updates, and book chapters. They also contributed more than 40 posters or presentations at national and international medical conferences. Links to each of the 2021 publications and […]

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Announces Allowance of Fourth U.S. Patent

By Natalie Themm | Published February 17, 2022

PolarityTE, Inc. announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application No. 17/326,734 filed on May 21, 2021.

Posted in BioUtah News | Tagged | Leave a comment

ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes

By Natalie Themm | Published February 17, 2022

ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list of America’s Best Midsize Employers for 2022.

Posted in BioUtah News | Tagged , | Leave a comment

Nexus Spine Appoints Steve Cichy as Vice President of Sales

By Natalie Themm | Published February 17, 2022

Appointment further expands leadership team to support aggressive commercialization of the company’s PressON™ fixation, Tranquil™ interbody, and pending technologies

Posted in BioUtah News | Tagged | Leave a comment

Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

By Natalie Themm | Published February 16, 2022

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Sciences 2021 Year-End Update

By admin | Published February 10, 2022

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to follow the science and invest in exceptional team members, advisors and consultants to help us modernize early-stage cancer detection.  LUNG Cancer – we have submitted our application to the FDA!! We have formally submitted our De Novo application to […]

Posted in BioUtah News | Leave a comment

Stanford Researchers cite BioPharm Laboratories High Purity Thrombin

By Natalie Themm | Published February 10, 2022

BioPharm Laboratories, another journal article from the Journal of Biological Chemistry cites the use of BioPharm’s High Purity Thrombin being used to cleave protein in their protein purification process.

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members